Allscripts Healthcare Solutions reported earnings of $406.2 million for this year’s quarter, a decrease of 8.6% from the same year.
The drop in profits was largely the result of minimizing patient volumes similar to the COVID-19 pandemic, Rick Poulton, president and monetary leader at Allscripts, said in a call with investment analysts On Thursday. Minimizing patient volumes had an effect on the proceeds of the company’s earnings cycle control service and the company’s payment clearing house, among other services.
Together, they account for about 10% of the company’s recurring revenue each quarter, Poulton said. Recurring revenue accounted for 82% of Allscripts’ quarterly revenue.
Poulton’s patient volumes had been recovering since June.
Allscripts withdrew its monetary outlook for 2020 in May due to pandemic uncertainty.
The company reported $188 million in quarter reserves, with $276 million in the 2019 quarter.
“Given the macroeconomic environment of the quarter, we are satisfied with the $188 million in reserves,” Poulton said.
The company recorded an operating loss of $4.7 million, down from $4.7 million in the operating source of reported revenue in last year’s quarter.
This included about $28 million in restructuring prices, basically severance pay, similar to a “margin improvement plan,” Poulton said. He said Allscripts does not expect the company to exceed more than $10 million in additional restructuring prices for the rest of the year, which would be split between the third and fourth quarters.
Allscripts announced its margin improvement plan last year. In March, the consulting firm hired AlixPartners to review its plan operations.
“My main goal is the company’s overhead,” Poulton said, stressing that he sought to focus on the power of sales, overall and administrative costs.
The Company’s adjusted earnings before interest, taxes, depreciation and amortization, or EBITDA, were 19% for the quarter, to 16.9% for the same era last year.
Allscripts also reached an agreement Thursday to sell EPSi, a business unit focused on monetary resolution support, to Strata Decision Technology for $365 million.
Allscripts and Strata Decision Technology expect to complete the transaction in the third quarter.
“The after-tax product will be used to eliminate leverage and increase our liquidity position,” Poulton said.
Allscripts has owned EPSi since the acquisition of Eclipsys in 2010.
Poulton stated that it was imaginable that Allscripts could get rid of more business units.
“Many corporations in the knowledge analysis and care coordination segment are corporations that do more business outdoors than the Allscripts EHR visitor base than internal ones and are very capable of defending themselves,” he said. “We don’t expect or announce anything, yet they are possibilities.”
Jessica Kim Cohen writes for Crain Modern Healthcare’s sister.
Do you have to get out of your chest? You can send us an email. Or tell us on our Facebook page or on Twitter, @CrainsChicago.
More contacts
Frequently Asked Questions / Customer Service